Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 2Classical hematology 1

Conditions

Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Anemia 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 5Tacrolimus 5Cyclosporine 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Whole-Body Irradiation 3Therapeutics 3Methotrexate 3Melphalan 3Cord Blood Stem Cell Transplantation 3Busulfan 3merphos 2Methylprednisolone 2Filgrastim 2Epoetin Alfa 2Darbepoetin alfa 2Antilymphocyte Serum 2obinutuzumab 1laromustine 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vorinostat 1Valganciclovir 1Transplantation 1Tetradecanoylphorbol Acetate 1Sucrose 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × obinutuzumab × Classical hematology × Clear all
NCT03010358 2023-08-08

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

OHSU Knight Cancer Institute

Phase 1/2 Completed
24 enrolled 16 charts
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Leukemia, Hairy Cell, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡